Skip to content
London Games Insight

Users Discontinuing Weight-Loss Injections Regain Weight Far More Rapidly Compared to Those on Conventional Diets

Illustration of pharmaceutical injection and scale
Weight management involves long-term strategies.

New research indicates that people who come off popular weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who stop traditional lifestyle regimens.

Findings released in a major medical journal demonstrates that while obese people frequently drop substantial amounts of their body weight while on the medication, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals buying these treatments need to be informed of the risk of rapid weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.

Such speed of regain implies a return to original weight within about a year and a half.

Comparing Approaches

The analysis, which examined 37 of trials involving thousands of participants, contrasted the outcomes of the injectable medications with conventional dieting.

Scientists point out that people who shed pounds through diet and exercise generally have a slower creep back—perhaps 0.1 kg a month—post-intervention.

The Reason for the Quick Rebound

Nutrition scientists suggest the way of the injections accounts for the accelerated weight return.

The injections imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 levels several times higher than normal may cause the system to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this hormone supplement means appetite is uncontrolled, making binge eating much more probable."

A Chronic Issue?

Health authorities recommend the jabs for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

A number of clinicians contend that, due to the significant potential of weight regain, the treatment is often long-term.

This perspective is supported by pharmaceutical companies, who say that the results "underscore the persistent nature of excess weight," similar to managing conditions like hypertension.

Patient Testimonies

People who have discontinued the jabs explain a intense resurgence of appetite.

"It felt as if a switch flipping and you're instantly extremely hungry," described one woman.

The struggle is worsened if patients have not established permanent lifestyle or habit changes during treatment.

Widespread Interest

Survey data indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire remaining high.

  • Adoption is greater among women compared to men.
  • The 40s and 50s demographic shows the greatest level of interest.
  • Many obtain the drugs through private prescriptions rather than public health services.

Ultimately, experts caution that while the jabs are powerful agents for shedding pounds, they are not a permanent fix and maintained weight loss hinges on integrated lifestyle management.

CP
About the author

Chad Patterson

A veteran game journalist with over a decade covering the UK gaming industry, focusing on indie gems and cultural impact.

London Games Insight

Type to search articles.